| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| XBP1P1 |
|
X-box binding protein 1 pseudogene 1
|
|
|
0.653 |
0.692 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| LOC390714 |
|
immunoglobulin heavy chain variable region
|
|
|
0.617 |
0.615 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR141 |
|
microRNA 141
|
|
|
0.497 |
0.808 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |
| MIR150 |
|
microRNA 150
|
|
|
0.455 |
0.808 |
| MIR152 |
|
microRNA 152
|
|
|
0.521 |
0.769 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR16-1 |
|
microRNA 16-1
|
|
|
0.623 |
0.500 |